#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3232172	B	Inhibition of bovine adrenal medullae dopamine-beta-hydroxylase	Bos taurus	20	ALA3227941	single protein format	Scientific Literature
2.	ALA3232173	F	Antiviral activity against HSV1 infected in African green monkey BSC-1 cells assessed as inhibition of virus multiplication at 50 ug/ml after 96 hrs by plaque reduction assay	Human alphaherpesvirus 1	17	ALA3227941	organism-based format	Scientific Literature
3.	ALA3232174	F	Antiviral activity against HSV1 infected in African green monkey BSC-1 cells assessed as inhibition of virus multiplication at 25 ug/ml after 96 hrs by plaque reduction assay	Human alphaherpesvirus 1	19	ALA3227941	organism-based format	Scientific Literature
4.	ALA3232175	F	Antiviral activity against HSV1 infected in African green monkey BSC-1 cells assessed as inhibition of virus multiplication at 12 ug/ml after 96 hrs by plaque reduction assay	Human alphaherpesvirus 1	20	ALA3227941	organism-based format	Scientific Literature
5.	ALA3232176	F	Antiviral activity against HSV1 infected in African green monkey BSC-1 cells assessed as inhibition of virus multiplication at 6 ug/ml after 96 hrs by plaque reduction assay	Human alphaherpesvirus 1	20	ALA3227941	organism-based format	Scientific Literature
6.	ALA3232178	F	Antiviral activity against Vaccinia virus infected in African green monkey BSC-1 cells assessed as inhibition of virus multiplication at 50 ug/ml after 96 hrs by plaque reduction assay	Vaccinia virus	17	ALA3227941	organism-based format	Scientific Literature
7.	ALA3232179	F	Antiviral activity against Vaccinia virus infected in African green monkey BSC-1 cells assessed as inhibition of virus multiplication at 25 ug/ml after 96 hrs by plaque reduction assay	Vaccinia virus	17	ALA3227941	organism-based format	Scientific Literature
8.	ALA3232180	F	Antiviral activity against Vaccinia virus infected in African green monkey BSC-1 cells assessed as inhibition of virus multiplication at 12 ug/ml after 96 hrs by plaque reduction assay	Vaccinia virus	19	ALA3227941	organism-based format	Scientific Literature
9.	ALA3232595	F	Antiviral activity against Vaccinia virus infected in African green monkey BSC-1 cells assessed as inhibition of virus multiplication at 6 ug/ml after 96 hrs by plaque reduction assay	Vaccinia virus	9	ALA3227941	organism-based format	Scientific Literature
10.	ALA3232596	F	Antiviral activity against Vaccinia virus infected in African green monkey BSC-1 cells assessed as inhibition of virus multiplication at 3 ug/ml after 96 hrs by plaque reduction assay	Vaccinia virus	4	ALA3227941	organism-based format	Scientific Literature
11.	ALA3232606	F	Antiviral activity against HSV1 infected in mouse assessed as assessed as protection against viral infection	Human alphaherpesvirus 1	1	ALA3227941	organism-based format	Scientific Literature
12.	ALA3230917	F	Antiviral activity against Vaccinia virus infected in mouse assessed as assessed as protection against viral infection	Vaccinia virus	1	ALA3227941	organism-based format	Scientific Literature
13.	ALA3230918	F	Antiviral activity against Transmissible gastroenteritis virus infected in pig at 25 mg/animal administered 3 times per day	Transmissible gastroenteritis virus	1	ALA3227941	organism-based format	Scientific Literature
14.	ALA3230919	T	Toxicity in Transmissible gastroenteritis virus infected pig at 25 mg/animal administered 3 times per day	Sus scrofa	1	ALA3227941	organism-based format	Scientific Literature
15.	ALA3230922	A	Cytotoxicity against Vaccinia virus infected African green monkey BSC1 cells at 100 ug/ml	Chlorocebus aethiops	10	ALA3227941	cell-based format	Scientific Literature